Risk-Based Monitoring Plan Developer for Case Review Steady-state Monitoring for Evidence Consolidation Deviation Triage
Develop a Risk-Based Monitoring (RBM) plan aligned with FDA's 2013 Oversight of Clinical Investigations guidance and ICH E6(R3) for a specific clinical trial.